CV
Cadrenal Therapeutics, Inc. Common Stock (CVKD)
NASDAQ·Healthcare·Biotechnology
$1.28
+13.57%
Mkt Cap $3.82M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$32.00
Range $32.00 – $32.00
Implied Upside
+2395.1%
Consensus $32.00 vs current $1.28